Inflammation: maladies, models, mechanisms and molecules

Br J Pharmacol. 2016 Feb;173(4):631-4. doi: 10.1111/bph.13389.

Abstract

The continued focus of attention on the diversity of mechanisms underpinning inflammation has improved our understanding of the potential to target specific pathways in the inflammatory network to achieve meaningful therapeutic gains. In this themed issue of the British Journal of Pharmacology our scope was deliberately broad, ranging across both acute and chronic disease in various organs. Pro- and anti-inflammatory mechanisms receive attention as does the phenotype of macrophages. Whilst the manifestations of neuro-inflammation are less obvious than those in peripheral tissues, central innate and adaptive immunity in brain and the M1/M2 phenotypes of microglia are topics of special interest. The contributions to the inflammatory milieu of cytokines, chemokines and associated signalling cascades are considered. Overall, the coverage herein advances the basic science underpinning our understanding of inflammation and emphasizes its importance in different pathologies.

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Brain / drug effects
  • Brain / metabolism*
  • Brain / pathology
  • Cytokines / metabolism
  • Humans
  • Inflammation / drug therapy
  • Inflammation / metabolism*
  • Inflammation / pathology
  • Models, Biological

Substances

  • Anti-Inflammatory Agents
  • Cytokines